plaloum
11-07-2022, 08:29 AM
The safety and efficacy of apixaban was demonstrated in the 18, 000 patient ARISTOTLE trial, which showed that in patients with nonvalvular AF, apixaban was superior to warfarin in preventing stroke and systemic embolism, caused less bleeding, and resulted in lower mortality than warfarin priligy and cialis ([Only registered and activated users can see links])